XML 119 R102.htm IDEA: XBRL DOCUMENT v3.25.0.1
Net Income (Loss) per Share Attributable to Common Stockholders - Schedule of Common Stock Equivalents Excluded from Calculation of Diluted Net Loss Per Share (Details) - shares
3 Months Ended 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2024
Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total (in shares) 8,148,887 42,666,887 45,414,332 42,666,887
Common stock warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total (in shares) 6,278,501 5,875,592 6,278,501 5,875,592
Restricted stock units        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total (in shares) 773,998 19,397,022 20,685,982 19,397,022
Stock options, including early exercise of options        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total (in shares) 906,767 17,173,007 14,260,228 17,173,007
Employee stock purchase plan shares        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total (in shares) 189,621 221,266 189,621 221,266
Value creation award vested shares        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total (in shares) 0 0 4,000,000 0